In-Vitro Transcription Templates Market

In vitro?transcription requires a purified linear DNA template containing a promoter, ribonucleotide triphosphates, a buffer system that includes DTT and magnesium ions, and an appropriate phage RNA polymerase. The exact conditions used in the transcription reaction depend on the amount of RNA needed for a specific application.
In-Vitro Transcription Templates Market contains market size and forecasts of In-Vitro Transcription Templates in global, including the following market information:
Global In-Vitro Transcription Templates Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global In-Vitro Transcription Templates Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five In-Vitro Transcription Templates companies in 2021 (%)
The global In-Vitro Transcription Templates market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of In-Vitro Transcription Templates include Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences, Inc. and Cytiva (Danaher). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the In-Vitro Transcription Templates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-Vitro Transcription Templates Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global In-Vitro Transcription Templates Market Segment Percentages, by Type, 2021 (%)
Cancer
Infectious Diseases
Lifestyle Diseases
Genetic Diseases
Others
Global In-Vitro Transcription Templates Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global In-Vitro Transcription Templates Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical & Biotechnology Companies
CROs & CMOs
Academics & Research
Others
Global In-Vitro Transcription Templates Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global In-Vitro Transcription Templates Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In-Vitro Transcription Templates revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies In-Vitro Transcription Templates revenues share in global market, 2021 (%)
Key companies In-Vitro Transcription Templates sales in global market, 2017-2022 (Estimated), (K Units)
Key companies In-Vitro Transcription Templates sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
Promega Corporation
Agilent Technologies, Inc.
New England Biolabs
Takara Bio Inc.
Lucigen Corporation
Enzynomics Co. Ltd.
Enzo Life Sciences, Inc.
Cytiva (Danaher)